Jia Tian, Kong Yezi, Zhao Guna, Wang Yu
Department of Child Healthcare, Northwest University First Hospital, Xi'an, Shaanxi, China.
Clinical Medical School, Haiyuan College, Kunming Medical University, Kunming, Yunnan, China.
Front Public Health. 2025 Sep 1;13:1609254. doi: 10.3389/fpubh.2025.1609254. eCollection 2025.
To evaluate the trends and cross-country inequalities of three common neurodevelopmental disorders (NDDs): Autism spectrum disorders (ASD), Attention-deficit/hyperactivity disorder (ADHD) and Idiopathic developmental intellectual disability (IDID) among children aged 0-14, and further predicted its changes to 2046.
The estimates and their 95% uncertainty interval (UI) for prevalence of ASD, ADHD and IDID among children aged 0-14 across 204 countries were extracted from Global Burden of Disease (GBD) 2021. Joinpoint regression analysis was used to calculate the average annual percentage changes (AAPC). The slope index of inequality (SII) and concentration index recommended by the World Health Organization (WHO) are two standard indicators for measuring absolute and relative gradient inequality. Our study used these two indicators to quantify the inequality of this three common NDDs burden between countries with different Sociodemographic Index (SDI). Finally, we used the Nordpred model to predict the disease burden of NDDs in 2046.
The AAPC (95% confidence interval [CI]) in prevalence of the three common NDDs among children aged 0-14 worldwide from 1990 to 2021 were as follows: ASD 0.09 (0.08 to 0.09), ADHD -0.08 (-0.12 to -0.04) and IDID -0.86 (-0.88 to -0.84). The SII (95% CI) changed from 27.09 (-29.98 to 84.17) in 1990 to 38.36 (-21.48 to 98.20) in 2021 for ASD, from 1402.78 (1100.25 to 1705.31) in 1990 to 1402.76 (1083.55 to 1721.97) in 2021 for ADHD, from -594.52 (-755.05 to -434.00) in 1990 to -545.94 (-673.19 to -418.69) in 2021 for IDID. The concentration index (95% CI) showed 0.15 (0.07 to 0.23) in 1990 and 0.19 (0.10 to 0.26) in 2021 for ASD, 0.07 (-0.02 to 0.16) in 1990 and 0.02 (-0.07 to 0.11) in 2021 for ADHD, 0.44 (0.34 to 0.53) in 1990 and 0.39 (0.28 to 0.48) in 2021 for IDID. Compared to 2021, the age-standardized prevalence rates (ASPR) in 2046 of the three common NDDs showed a slight decrease in ASD and ADHD, a slight increase in IDID.
As a major public health concern, the global burden of NDDs in children exhibited distinct trends from 1990 to 2021: an increasing trend for ASD, and decreasing trends for ADHD and IDID. Health inequalities persist across these conditions. The burdens of ASD and ADHD are primarily concentrated in high-SDI countries/territories, whereas the burden of IDID is more prevalent in low-SDI countries/territories. Therefore, targeted public health strategies and equitable allocation of healthcare resources are essential to effectively mitigate the burden of NDDs.
评估三种常见神经发育障碍(NDDs)在0至14岁儿童中的发展趋势及国家间不平等情况,这三种疾病分别为自闭症谱系障碍(ASD)、注意力缺陷多动障碍(ADHD)和特发性发育性智力残疾(IDID),并进一步预测其到2046年的变化。
从《2021年全球疾病负担》(GBD 2021)中提取了204个国家0至14岁儿童中ASD、ADHD和IDID患病率的估计值及其95%不确定性区间(UI)。采用Joinpoint回归分析计算平均年度百分比变化(AAPC)。世界卫生组织(WHO)推荐的不平等斜率指数(SII)和集中指数是衡量绝对和相对梯度不平等的两个标准指标。本研究使用这两个指标来量化不同社会人口指数(SDI)国家间这三种常见NDDs负担的不平等情况。最后,我们使用Nordpred模型预测2046年NDDs的疾病负担。
1990年至2021年全球0至14岁儿童中三种常见NDDs患病率的AAPC(95%置信区间[CI])如下:ASD为0.09(0.08至0.09),ADHD为 -0.08(-0.12至 -0.04),IDID为 -0.86(-0.88至 -0.84)。ASD的SII(95% CI)从1990年的27.09(-29.98至84.17)变为2021年的38.36(-21.48至98.20),ADHD的SII从1990年的1402.78(1100.25至1705.31)变为2021年的1402.76(1083.55至1721.97),IDID的SII从1990年的 -594.52(-755.05至 -434.00)变为2021年的 -545.94(-673.19至 -418.69)。集中指数(95% CI)显示,ASD在1990年为0.15(0.07至0.23),2021年为0.19(0.10至0.26);ADHD在1990年为0.07(-0.02至0.16),2021年为0.02(-0.07至0.11);IDID在1990年为0.44(0.34至0.53),2021年为0.39(0.28至0.48)。与2021年相比,2046年三种常见NDDs的年龄标准化患病率(ASPR)显示ASD和ADHD略有下降,IDID略有上升。
作为一个主要的公共卫生问题,1990年至2021年儿童NDDs的全球负担呈现出不同的趋势:ASD呈上升趋势,ADHD和IDID呈下降趋势。这些疾病的健康不平等现象持续存在。ASD和ADHD的负担主要集中在高SDI国家/地区,而IDID的负担在低SDI国家/地区更为普遍。因此,有针对性的公共卫生策略和医疗资源的公平分配对于有效减轻NDDs的负担至关重要。